Century Therapeutics Adds Respected Biotech Executives to Board of Directors

PHILADELPHIA: PHILADELPHIA, June 1, 2021 /PRNewswire/ -- Century Therapeutics, a leading cell therapy company developing induced pluripotent stem cell (iPSC)-derived cell therapies in immuno-oncology, today announced the appointment of Alessandro Riva, M.D., and Kimberly Blackwell, M.D., as new Independent Directors. A former Executive Vice President at Gilead Sciences and Novartis...

Click to view original post